BioXcel Therapeutics

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.

VantAI is an AI application focused on generative AI-enabled drug discovery. Their mission is to unlock a new chapter in medicine by making protein interactions programmable. They have an integrated discovery platform with phase-shifting technologies designed to unlock the full potential of the proximity modulator modality. VantAI collaborates with industry leaders to build the future of therapeutic design. The company has launched Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

GenInnov is a generative innovation fund that provides a platform for investors seeking to be at the forefront of technological advancement. The fund invests in companies driving transformative change across multiple sectors and geographies, prioritizing material innovations with demonstrable profitability and global reach. GenInnov operates with a research-driven approach, focusing on investing in material innovations that are monetizable, profitable, and transformative, rather than incremental. The fund looks at various domains such as technology, robotics, consumer electronics, biotech, healthcare, mobility, and clean tech, aiming to amplify human creativity through machine intelligence.

Amazon Science is a research and development organization within Amazon that focuses on developing new technologies and products in the fields of artificial intelligence, machine learning, and computer science. The organization is home to a team of world-renowned scientists and engineers who are working on a wide range of projects, including developing new algorithms for machine learning, building new computer vision systems, and creating new natural language processing tools. Amazon Science is also responsible for developing new products and services that use these technologies, such as the Amazon Echo and the Amazon Fire TV.

HealthITAnalytics is a leading source of news, insights, and analysis on the use of information technology in healthcare. The website covers a wide range of topics, including artificial intelligence, machine learning, data analytics, and population health management. HealthITAnalytics also provides resources for healthcare professionals, such as white papers, webinars, and podcasts.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Cambrian Copilot is an AI tool designed for researchers and engineers to stay up-to-date with the latest machine learning research. The tool enables users to search over 240,000 ML papers, understand complex details, and automate literature reviews. It simplifies the process of discovering and accessing the most recent research developments in the field of machine learning.

Mnemonic AI is an advanced Customer Intelligence AI tool that specializes in creating AI Personas and Digital Twins of customers. The tool helps organizations of all sizes better understand individuals by developing artificial intelligence solutions to tailor messages based on customer beliefs, personality, and values. Mnemonic AI offers features such as Buyer Persona Creation, Digital Twin of The Customer, Case Studies, Whitepaper, OCEAN Personality Analysis, Schwartz Universal Values, and easy integrations with data sources.

functime is a time-series machine learning tool designed to perform forecasting tasks at scale. It provides a comprehensive set of functions and features to help users analyze and compare trends, seasonality, and causal factors in their forecasts. With easy installation via pip, detailed documentation, and a user-friendly tutorial, functime is suitable for both beginners and experienced users in the field of machine learning. The tool offers evaluation procedures for scoring, ranking, and plotting thousands of forecasts simultaneously, making it a valuable asset for data analysts and forecast analysts.

Kolank is an AI tool that offers a unified API for various AI models with features like load balancing, fallbacks, cost and performance metrics. It provides access to a range of models for tasks such as text generation, image analysis, and video processing. Users can interact with the API using popular programming languages like Python and JavaScript, as well as through command-line tools like Curl. Kolank aims to simplify the integration of AI capabilities into applications and workflows, making it easier for developers to leverage advanced AI technologies.

StockGPT is an AI-powered financial research assistant that provides users with knowledge of earnings releases, financial reports, and other fundamental information for S&P 500 and Nasdaq companies. It offers features like AI search, customizable filters, industry research, and up-to-date data to help users analyze companies and markets more efficiently.

XenonStack is an AI tool that offers a comprehensive suite of solutions for building agentic systems, leveraging cutting-edge technologies like AI, data analytics, and automation. The platform caters to various industries and business sectors, providing services such as AI transformation, decision modeling, AI assurance, and cloud architecture. XenonStack aims to enhance business workflows, optimize decision-making processes, and drive operational efficiency through the deployment of intelligent AI agents and automation.

Google Colab Copilot is an AI tool that integrates the GitHub Copilot functionality into Google Colab, allowing users to easily generate code suggestions and improve their coding workflow. By following a simple setup guide, users can start using the tool to enhance their coding experience and boost productivity. With features like code generation, auto-completion, and real-time suggestions, Google Colab Copilot is a valuable tool for developers looking to streamline their coding process.

Data Zenith is a Kolkata-based startup specializing in innovative data analytics solutions. They offer tailored analytics services to help businesses unlock the potential of their data, streamline operations, and make informed decisions for sustainable growth. With a team of experienced data scientists, Data Zenith provides comprehensive data analysis, predictive analytics, and data visualization services to drive actionable insights and enhance operational efficiency.

Lobe is a machine learning tool that helps users train machine learning models and ship them to any platform of their choice. It provides a user-friendly interface for creating and managing machine learning projects, making it easy for both beginners and experienced users to work with AI models.

Aitodata.com is an AI-powered data analysis platform that empowers users to extract valuable insights from their data effortlessly. The platform offers a user-friendly interface and advanced algorithms to help users analyze, visualize, and interpret data in a meaningful way. With Aitodata.com, users can streamline their data analysis process, make data-driven decisions, and uncover hidden patterns and trends within their datasets.

GPT-4 Consulting is an AI tool designed to provide business advice and consultation services. The platform utilizes advanced AI technology, specifically GPT-4, to offer tailored recommendations and insights for leveraging AI in business operations. Users can book consultations to receive personalized advice on various aspects of their business, from strategy development to implementation of AI solutions. The tool aims to help businesses optimize their processes, enhance decision-making, and stay competitive in the rapidly evolving digital landscape.

Weaviate is an AI-native database that developers love. It offers a vector database for intuitive AI-native applications, hybrid search capabilities, and agentic AI workflows. Weaviate empowers developers to build and scale modern AI applications more easily, with flexible cost-performance optimization and robust developer community support.

DataWise is an AI application that empowers businesses with artificial intelligence solutions. Founded in 2024, DataWise offers smart, scalable, and intuitive AI-driven features to drive growth and efficiency. With a team of expert data scientists and engineers, DataWise provides custom AI solutions tailored to unique business challenges. The platform includes advanced data analytics, operations automation, NLP for language processing, and custom AI model development.

Qualifyed is an AI predictive audiences and lead scoring platform designed to help businesses optimize their advertising efforts by targeting potential customers with the highest probability of conversion. By leveraging machine learning technology, Qualifyed analyzes data to identify targetable individuals with a high likelihood of making a purchase. The platform offers a comprehensive solution for media buying, allowing users to proactively reach out to prospects and optimize their advertising campaigns across various channels. With a focus on reducing customer acquisition costs and increasing conversion rates, Qualifyed aims to revolutionize the way businesses approach lead generation and sales.

Chessvision.ai is an AI-powered eBook reader that leverages Artificial Intelligence and Computer Vision to enhance the study experience of chess enthusiasts. The application supports PDF, ePub, and DjVu formats, allowing users to interact with chess diagrams, add comments, search positions from online bases, watch YouTube videos, and analyze positions with the engine. It is a highly recommended tool for chess players of all levels looking to study and improve their game.

Vectara is a conversational search demo that showcases the capabilities of a search tool powered by natural language processing. The tool allows users to interact with the search engine using conversational language, making the search process more intuitive and user-friendly. By enabling JavaScript, users can experience the demo and explore how conversational search can enhance their search experience.

Susterra is an advanced analytics platform for Public Finance that empowers stakeholders with powerful insights to catalyze urban development. It integrates leading practices from academia, leverages public data growth, and utilizes technology innovations like ML and AI to enable issuers to make suitable choices for accelerating the development of Smart Cities across the United States.

Collective[i] is an AI-powered platform that helps businesses optimize their sales processes through data-driven insights and automation. The platform leverages deep learning to automate tasks, improve decision-making, and enhance the overall buying experience. By utilizing AI technology, Collective[i] enables organizations to forecast sales, improve productivity, expand margins, and grow revenue. The platform offers applications such as Intelligent WriteBack™ for data cleansing and automation, C[i]™ for Sales for buyer-centric selling, and Intelligence.com® for supporting a community of business connectors. Collective[i] prioritizes enterprise-level security and privacy to ensure the confidentiality and integrity of client data.

The AI SDK is a free open-source library designed to empower developers to build AI-powered products. It offers a unified Provider API, allowing users to easily switch between AI providers with a single line of code. The SDK enables the creation of dynamic, AI-powered user interfaces and supports various frameworks like React, Next, Vue, Nuxt, and SvelteKit. It also provides the ability to stream AI responses instantly, enhancing user experience. The AI SDK has received high praise from developers for its ease of use, speed of development, and comprehensive documentation.